<DOC>
	<DOCNO>NCT00566878</DOCNO>
	<brief_summary>The objective determine alglucosidase alfa present breast milk mother Pompe Disease treat alglucosidase alfa measure breast milk production composition woman Pompe Disease receive alglucosidase alfa .</brief_summary>
	<brief_title>Pompe Lactation Sub-Registry</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Glycogen Storage Disease</mesh_term>
	<criteria>Must enrol Pompe Registry ( NCT00231400 ) Must pregnant intend breastfeed currently lactate receive least one infusion alglucosidase alfa lactate Provide sign Patient Information Authorization form participate subregistry prior subregistryrelated assessment perform Agree adhere subregistry guideline antibody test recommend schedule assessment . Patients exclude subregistry receive investigational drug ( exclude alglucosidase alfa region alglucosidase alfa commercially available ) within 30 day prior Visit 1 breast milk collection</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Glycogen Storage Disease</keyword>
	<keyword>GSD-II</keyword>
	<keyword>Pompe Disease</keyword>
	<keyword>Pompe Disease ( Late-Onset )</keyword>
	<keyword>Acid Maltase Deficiency Disease</keyword>
	<keyword>Glycogenosis II</keyword>
</DOC>